Woomera Therapeutics

Woomera TherapeuticsWoomera TherapeuticsWoomera Therapeutics
  • Sign In
  • Create Account

  • Orders
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Orders
  • My Account
  • Sign out

  • Home
  • Product list
  • Contact Us
  • Shop
  • More
    • Home
    • Product list
    • Contact Us
    • Shop

Woomera Therapeutics

Woomera TherapeuticsWoomera TherapeuticsWoomera Therapeutics

Signed in as:

filler@godaddy.com

  • Home
  • Product list
  • Contact Us
  • Shop

Account


  • Orders
  • My Account
  • Sign out


  • Sign In
  • Orders
  • My Account

VASOPRESSIN ANTIBODIES (FZE)

Product Name: Rabbit Arginine-Vasopressin Antibodies (FOZZIE, FZE)

This is an antibody preparation generated in rabbit by Dr. William North Professor of Physiology and Neurobiology of Dartmouth Medical School (now Geisel Medical School at Dartmouth) using arginine- vasopressin coupled to bovine thyroglobulin. 


Specificity: Less than 0.1% cross-reactivity with oxytocin, in RIA 


Tested Applications IHC-formaldehyde fixed tissues, Flow cytometry, , RIA, ELISA 


Properties 


Form:                              Liquid 


Storage Instructions: Shipped at 4 o C. Store at 4 o C short term (1-2 weeks). Upon delivery aliquot and store at -20 o C or -80 o C. Avoid freeze/Thaw cycling. 


Storage buffer:           Preservative none -Stable if stored as 1:100 dilutions in PBS containing  1.25 mg/ml of BSA at -20 o C. 


Constituents:              Whole serum 


Purity:                           Whole Antiserum 


Clonality:                     Polyclonal 


Isotype:                       IgG, Behaves chromatographically like mouse IgG2B 


Research Areas:       Neuroscience, Endocrinology, Neuropeptides, Hormones,  Neuroendocrinology, OBGYN, Cancer  


----------------------------------------------------------------------------------


Woomera Therapeutics Inc. guarantees use of FZE in each of the tested applications: 

The application information recommends certain starting dilutions; however, optimal dilutions/concentrations should be determined by the end user. 


Application  


IHC:                           Use at an assay dependent concentration 

RIA:                            1/30,000-99,000. Sensitivity to 0.4 pg/ml; 50% displacement ~5 pg,  range 0.4-32 pg; <0.1% OT cross-reaction.  


ELISA:                         1/30,000-50,000 


Flow Cytometry:      1/1000-5000 


Western:                    1/1000-5000


References


North, W.G. Neuropeptide production by small-cell carcinoma: Vasopressin and oxytocin as plasma markers of disease. J. Clin. Endocrin. Metab. 73:1316-1320, 1991. 

Cheng, S.W.T., and North, W.G. Absence of negative feedback by oxytocin on release from magnocellular neurones in conscious rats. Can. J. Physiol. Pharmacol. 70(1):100-105, 1992.

Piqueux, C., Hagelstein M.T., Keegan, B., Legros, V., and North, W.G. Vasopressin and Oxytocin mitogen transduction pathway in small cell lung cancer cells. Endocr.-Relat. Cancer, 4:871- 875, 2004.  


Product Code FZE


Copyright © 2025 Woomera Therapeutics - All Rights Reserved.

  • Privacy Policy
  • Terms and Conditions

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept